E-LIB Suche - Ergebnisse für: Wörns, M.

1

Safety and effectiveness of Regorafenib in recurrent HCC af..:

Invernizzi, F. ; Iavarone, M. ; Czauderna, C....
Digestive and Liver Disease. 51 (2019) - p. e12 , 2019

Link: https://doi.org/10.1016/..

2

Das hepatozelluläre Karzinom:

Czauderna, C. ; Marquardt, J. U. ; Galle, P. R..
best practice onkologie. 13 (2018) 1 - p. 42-51 , 2018

Link: https://doi.org/10.1007/..

3

Prospective evaluation of the impact of covert hepatic ence..:

Labenz, C. ; Baron, J. S. ; Toenges, G....
Alimentary Pharmacology & Therapeutics. 48 (2018) 3 - p. 313-321 , 2018

Link: https://doi.org/10.1111/..

4

A high alpha-fetoprotein slope prior to therapy correlates ..:

Czauderna, C. ; Koch, S. ; Pilz, L....
Journal of Hepatology. 68 (2018) - p. S442 , 2018

Link: https://doi.org/10.1016/..

5

Persistent improvement of liver function tests and health-r..:

Huber, Y. ; Pfirrmann, D. ; Gebhardt, I....
Journal of Hepatology. 68 (2018) - p. S580 , 2018

Link: https://doi.org/10.1016/..

6

Editorial: covert hepatic encephalopathy—silent but serious..:

Labenz, C. ; Wörns, M.‐A.
Alimentary Pharmacology & Therapeutics. 48 (2018) 4 - p. 480-481 , 2018

Link: https://doi.org/10.1111/..

7

Health-related quality of life correlates with histological..:

Huber, Y. ; Labenz, C. ; Siebler, T....
Journal of Hepatology. 68 (2018) - p. S831-S832 , 2018

Link: https://doi.org/10.1016/..

8

Application of patient-derived liver cancer cells for perso..:

Castven, D. ; Becker, D. ; Czauderna, C....
Journal of Hepatology. 68 (2018) - p. S683 , 2018

Link: https://doi.org/10.1016/..

9

Validation of the MESH, HKLC and BCLC classification in a l..:

Franck, S. ; Schmidtmann, I. ; Heil, E....
Journal of Hepatology. 68 (2018) - p. S446-S447 , 2018

Link: https://doi.org/10.1016/..

10

Treatment efficacy and safety of seladelpar, a selective pe..:

Hirschfield, G. ; Boudes, P. ; Bowlus, C....
Journal of Hepatology. 68 (2018) - p. S105-S106 , 2018

Link: https://doi.org/10.1016/..

11

Efficacy and safety of glecaprevir/pibrentasvir in renally-..:

Persico, M. ; Flisiak, R. ; Abunimeh, M....
Journal of Hepatology. 68 (2018) - p. S292 , 2018

Link: https://doi.org/10.1016/..

12

Hepatocyte-specific deletion of type I interleukin-1 recept..:

Gehrke, N. ; Hövelmeyer, N. ; Waisman, A....
Journal of Hepatology. 66 (2017) 1 - p. S341 , 2017

Link: https://doi.org/10.1016/..

13

Pharmacokinetics and safety of glecaprevir/pibrentasvir in ..:

Gane, E. ; Poordad, F. ; Valdes, J....
Journal of Hepatology. 66 (2017) 1 - p. S306 , 2017

Link: https://doi.org/10.1016/..

14

Das hepatozelluläre Karzinom:

Czauderna, C. ; Marquardt, J. U. ; Galle, P. R..
Der Internist. 58 (2017) 5 - p. 469-479 , 2017

Link: https://doi.org/10.1007/..

15

Improved prediction of survival by a risk factor-integrated..:

Sprinzl, M.F. ; Koch, S. ; Seib, M.L....
Journal of Hepatology. 66 (2017) 1 - p. S452-S453 , 2017

Link: https://doi.org/10.1016/..